FindTrial
Sign In

Safety of gastrectomy after non-curative endoscopic submucosal dissection

Operative Safety of Curative Gastrectomy after Endoscopic Submucosal Dissection (ESD) for Early Gastric Cancer: 1:2 propensity score matching analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004893
Enrollment
1181
Registered
2020-04-06
Start date
2019-08-20
Completion date
Unknown
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: From 2009 to 2016, patients who diagnosed gastric cancer with clinical T1 stage who underwent additional gastrectomy after non-curative endoscopic submucosal dissection or standard gastrectomy without endoscopic submucosal dissection at Seoul St. Mary’s Hospital

Exclusion criteria

Exclusion criteria: (1) incomplete pathologic data (2) gastrectomy >1 year after endoscopic submucosal dissection (3) less than 16 retrieved lymph nodes (4) additional malignancies

Design outcomes

Primary

MeasureTime frame
Postoperative complication—

Secondary

MeasureTime frame
Pathologic N stage—

Countries

Korea, Republic of

Contacts

Public ContactKi Bum Park

The Catholic University of Korea, St. Vincent's Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026